Arkema | AKE - Cash And Equivalent


Arkema reported EUR2.19B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Air Products & Chemicals USD 951M 75.4M Mar/2026
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 1.62B 66M Dec/2025
Arkema EUR 2.19B 235M Dec/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 6.67B 774M Dec/2025
Covestro EUR 648M 44M Dec/2025
Croda International GBP 157.8M 9M Jun/2025
Givaudan CHF 603M 3M Jun/2024
IMCD EUR 236.09M 45.66M Dec/2025
Johnson Matthey GBP 542M 49M Jun/2024
Kemira EUR 242.3M 134.5M Dec/2025
Lenzing EUR 662.7M 94.8M Mar/2026
Linde USD 3.96B 1.1B Mar/2026
PPG Industries USD 1.57B 590M Mar/2026
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 486M 50M Mar/2026
Umicore EUR 1.56B 450.17M Dec/2025